Solutions Pediatric Therapy Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 7305 Old Hecker Rd, Iowa, LA 70647 Phone: 337-358-9699 |
News Archive
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
Centene Corporation today announced that its South Carolina subsidiary, Absolute Total Care, has signed a definitive agreement to acquire Columbia-based Carolina Crescent Health Plan (CCHP), the state's largest non-profit Medicaid managed care organization, from University Health Services, Inc. (UHS). CCHP serves more than 40,000 Medicaid members in 46 counties across the state.
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).
Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.
According to an international study older women should not take Hormone Replacement Therapy (HRT).
› Verified 7 days ago